Nerve Assessment Index: A New Rating Tool for Peripheral Nerve Coaptations in Sharp Nerve Transections Authors: Vincent G.J. Guillaume, Tim Leypold, Leonie Scheve, Justus P. Beier, Benedikt Schäfer Published: 2026 ABSTRACT Summary:Peripheral nerve injuries represent a significant clinical challenge, often resulting in long-term sensory and motor deficits, disability, and reduced quality of life. Despite advances in microsurgical techniques and regenerative medicine, the functional outcomes following nerve repair remain highly variable and unpredictable. One critical factor influencing success is the quality of the initial nerve coaptation. Currently, there is no standardized, objective tool for assessing the quality of nerve coaptation during surgery. This lack of uniform assessment criteria hinders meaningful comparison between surgical techniques and limits the reproducibility of experimental and clinical studies. To address this gap, we proposed the development of a novel rating system—the “Nerve Assessment Index”—designed to evaluate the anatomical and morphological quality of nerve coaptation. By providing a structured, reproducible framework for scoring nerve repairs, the Nerve Assessment Index aims to harmonize reporting standards in both clinical and preclinical settings, improve intraoperative decision-making, and facilitate more robust comparisons across studies. Ultimately, this tool may promote more consistency, transparency, and higher quality evidence in peripheral nerve surgery. Takeaways Question: Does our newly designed rating tool address the current lack of a standardized rating system for nerve coaptations? Findings: The Nerve Assessment Index comprises 4 criteria, with a total of 12 points achievable, which evaluate different aspects of a nerve coaptation. Criterion 1 scores the traction and tension of nerve coaptation, whereas criterion 2 rates the alignment of the nerve stumps. The equal distribution of stitches and the correct bide width are evaluated by criteria 3 and 4. Meaning: The Nerve Assessment Index aims to harmonize reporting standards and to facilitate more robust comparisons across preclinical and clinical studies. INTRODUCTION Peripheral nerve injuries (PNIs) are relatively common and clinically significant types of injuries, with an estimated incidence of approximately 11.2 to 16.9 cases per 100,000 individuals annually.1,2 The majority of these injuries affect the upper extremities, particularly at or distal to the wrist, where nerves are more exposed and vulnerable to trauma.1 The mechanism of nerve injury plays a significant role in the expected outcome, with light traction and compression injuries leading to neuropraxia holding the greatest potential for full recovery, whereas extensive crush or full transection injuries cause significantly greater damage to the nerve.3 Despite advancements in microsurgical techniques and the development of structured postoperative rehabilitation protocols, PNIs continue to be associated with considerable morbidity.4 They often lead to prolonged recovery periods, persistent functional impairment, and highly variable clinical outcomes.4 The classification of PNIs has traditionally followed Sunderland’s 5-grade system, which categorizes injuries from neuropraxia (transient conduction block) to neurotmesis (complete transection of the nerve), with 3 intermediate degrees of axonotmesis reflecting increasing severity.5 Building upon this classification system, Mackinnon6 and Dellon later introduced a sixth degree, acknowledging that mixed patterns of injury can coexist within a single nerve, which negatively impacts the recovery of the affected nerve.4 Recently, a new classification for the intraoperative assessment of obstetric brachial plexus injuries has been proposed by Bahm et al,7 which integrates morphological features with histopathologic findings, further expanding the number of rating systems for nerve injuries. METHODS Although considerable effort has been made to improve nerve repair techniques,8,9 a critical gap remains: there is currently no standardized tool to objectively assess the quality of nerve coaptation. The absence of such a metric limits interstudy comparability, impairs reproducibility, and poses challenges for evaluating surgical success—underscoring the need for a reliable, harmonized rating system. For microsurgical anastomoses, for example, the microsurgical anastomosis rating scale-rating system and the Anastomosis Lapse Index represent established evaluation tools that are used throughout various microsurgical studies allowing cross-comparison.10–12 Due to the lack of a standardized rating system for the quality of nerve coaptations in sharp transection injuries (or nerve transfers, where straight nerve transection areas are also created), we propose the “Nerve Assessment Index (NervAIX)”—a rating metric that aims to harmonize reporting standards and to facilitate more robust comparisons across preclinical and clinical studies. NervAIX was derived from an extensive literature review of current published data on nerve coaptation by sutures and its impact on nerve regeneration, conducted before designing this rating, along with a panel discussion within the authors’ group about each criterion and its weighting. The NervAIX consists of 4 scoring criteria, with 0, 2, and 4 points assigned to criteria 1 and 2, and 0 to 2 points assigned to criteria 3 and 4, allowing for a total of 12 points (Table 1). Furthermore, the use of fibrin glue as a sealant for the coaptation side should be noted: Table 1.Description of the 4 Criteria of the NervAIX Rating: Coaptation Tension (Criterion 1), the Alignment of the Fascicles/Nerves (Criterion 2), the Symmetry of Stitches (Criterion 3), and Stitch Depth (Criterion 4)CriteriaPoints024Criterion 1: compression- and traction-free coaptationBulging or dehiscence of nerve stumps (Fig. 1; Supplemental Digital Content 1, https://links.lww.com/PRSGO/E851)Raised or dragged nerve stumpsTension-free coaptation without compression or tractionCriterion 2: alignment of nerve stumps and fasciclesInverted or extruding fascicles and nerve stumps or steps between nerve stumps (Fig. 2)Slight misalignment of fascicles or nerve stumpsCorrect alignment of fascicles and nerve stumps without inversion, extrusion, or step formationPoints012Criterion 3: distribution and orientation of stitchesAsymmetrical distribution and orientation of stitches with oblique placement or clustering of stitches (Fig. 3)Slight asymmetrical distribution and orientation of stitchesSymmetrical distribution and orientation of stitchesCriterion 4: epineural stitch depth and bite widthEndoneurial/perineural stitches or grossly grasping of excessive tissue (Fig. 4)Perineural stitches or grasping of too much or too little tissueEpineural stitches with the desired bite width and correct position of the knotReporting of the usage of fibrin glue as an adjunct to the nerve coaptation side: Yes/No. Description of the 4 Criteria of the NervAIX Rating: Coaptation Tension (Criterion 1), the Alignment of the Fascicles/Nerves (Criterion 2), the Symmetry of Stitches (Criterion 3), and Stitch Depth (Criterion 4) Reporting of the usage of fibrin glue as an adjunct to the nerve coaptation side: Yes/No. Criterion 1: Compression- and traction-free coaptation. Criterion 1: Compression- and traction-free coaptation. Criterion 2: Alignment of nerve stumps and fascicles. Criterion 2: Alignment of nerve stumps and fascicles. Criterion 3: Distribution and orientation of stitches. Criterion 3: Distribution and orientation of stitches. Criterion 4: Epineural stitch depth and bite width. Criterion 4: Epineural stitch depth and bite width. Reporting of the use of fibrin glue as an adjunct. Reporting of the use of fibrin glue as an adjunct. The assessment is designed for sharp nerve injuries with end-to-end nerve coaptations. Observer judgment should be performed under default conditions, with complete illumination of the operating field and the use of magnifying glasses or an operating (stereo) microscope with at least 3× magnification to enable sufficiently valid estimation of the different scoring parameters (Figs. 1–4). (See figure, Supplemental Digital Content 1, which depicts elevated traction on the nerve coaptation resulting in dehiscence of the nerve stumps [criterion 1], https://links.lww.com/PRSGO/E851.) Nerve coaptation with excessive tension on the nerve stumps, resulting in bulging of the nerve stumps (criterion 1). Misalignment of nerve stumps, with a step between the 2 nerve stumps and an additional twisting of the distal nerve stump (criterion 2). Asymmetry of sutures, with oblique and clustered stitches (criterion 3). Cross-sectional view of a nerve stump illustrating criterion 4, with various depth levels of stitches: overly deep sutures with excessive tissue capture, a correct epineural suture, and a superficial suture with thread pullout before coaptation. RATIONALE The NervAIX classification system comprises the concept of ideal nerve coaptation: a correctly aligned, tension-, and traction-free coaptation with even distribution of epineural stitches and correct bide width. (See figure, Supplemental Digital Content 2, which illustrates ideal nerve coaptation with correctly aligned, tension-, and traction-free coaptation, and even distribution of epineural stitches with a correct bide width, https://links.lww.com/PRSGO/E852.) This coaptation technique should render optimal nerve regeneration in terms of the coaptation itself. Multiple additional factors affect the clinical outcome, such as excessive scarring around the nerve or its perfusion. However, adhering to the principles of the ideal nerve coaptation lays the groundwork for the desired nerve regeneration. We believe that a harmonized reporting practice, such as the NervAIX rating, can enhance the comparability of surgical outcomes, reduce interobserver variability, and promote consistency in data collection and interpretation. DISCUSSION Within the operating room, the NervAIX has the potential to support intraoperative decision-making by offering surgeons an objective reference to guide and evaluate their repair techniques in real time to achieve optimal nerve coaptation. One limitation of our rating system is that it does not account for the number of sutures placed circumferentially around the nerve. Given that suture material induces a foreign body response with local inflammation—both of which can negatively impact axonal regeneration—the number of stitches should ideally be proportionate to the nerve’s circumference. However, in the absence of an established standard or “golden ratio” linking suture quantity to nerve diameter and fundamental research data, we deliberately excluded the absolute number of stitches from the rating, bearing this limitation in mind. Furthermore, we did not include the application of sealants such as fibrin glue or a nerve wrap with veins or commercial products as a replacement for microsurgical nerve coaptation by epi-/perineural sutures, as the current data lack comprehensive, high-quality studies that broadly substantiate the usefulness of their application. So far, data most likely indicate nonsuperior results compared with the gold standard of direct suture repair.13,14 Furthermore, when establishing such a novel rating system, we first wanted to focus on the most common and frequently used technique for nerve coaptation, which still is microsurgical suturing. However, the concept of using these materials as an adjunct to protect the coaptation site against traction, modify the microenvironment to reduce scarring, and inhibit neuroma formation is appealing. Among these, the additional application of fibrin glue is supported by current published data.15 Thus, the usage of fibrin glue should also be reported to increase overall comparability of the nerve coaptation assessment. The NervAIX is designed with broad applicability, offering a standardized assessment tool that can be integrated into preclinical experimental studies to evaluate surgical techniques and novel biomaterials for nerve coaptation, as well as into clinical research to support outcome comparisons, quality control, and the development of evidence-based guidelines for peripheral nerve repair. With new technical developments such as microsurgical robots, for example, the Symani Surgical System (MMI, Pisa, Italy) or the MUSA3 System (Microsure, Eindhoven, Netherlands), which is currently under development, standardized rating systems are essential to compare the quality and efficacy of nerve coaptations and to generate valuable data.9,12 However, the significance of such a classification system is directly proportional to its widespread use and its predictive positive and negative values. Thus, we would like to see the NervAIX rating system broadly applied throughout preclinical and clinical studies. First and foremost, the validity and prognostic significance of our nerve assessment must be independently investigated in animal experiments, whereby the model of sciatic nerve injury in rodents, for example, represents a suitable model.16 Furthermore, as a second step, validation of this tool in terms of its prognostic value (ie, determining its positive/negative predictive values) by correlating scores with clinical outcomes will be a major task for the future. A sufficiently long follow-up period, as well as a large patient cohort, is planned for a comprehensive clinical study. Although the grading is based on objective parameters per se, retrieving these data is nonetheless susceptible to subjective bias, which could potentially impact the overall score. Therefore, interoperator variability should be examined when conducting prospective studies. CONCLUSIONS We present a novel nerve coaptation rating, the NervAIX, which comprises the concept of ideal nerve coaptation. The introduction and establishment of such a rating system have the potential to harmonize reporting standards, enable greater interstudy comparability, and generate more valuable data. This could promote surgical outcomes by identifying surgical innovations and techniques that truly lead to enhanced results. However, future studies should aim to evaluate the predictive value of the individual category scores with respect to clinical outcomes. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. ACKNOWLEDGMENTS Artificial intelligence was used for language improvements (grammar and spelling corrections), with all generated corrections reviewed and edited as necessary. All authors take full responsibility for the content of the publication. Supplementary Material